NewsAvi Kapoor
Adagio Medical Holdings
ADGM · NASDAQ
$0.1208+$0.0008 (+0.67%)TodayMarket closed ·
Prev close $0.12
Latest news
- NewsAvi Kapoor
Dow Falls 100 Points; General Mills Posts Upbeat Q1 Earnings
- Press releaseBusiness Wire
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
- Press releaseBusiness Wire
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
- Press releaseBusiness Wire
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
- Press releaseBusiness Wire
Adagio Medical Reports Second Quarter 2026 Results
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Palantir Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
- NewsTanya Rawat
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours
- Press releaseBusiness Wire
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseBusiness Wire
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
- Press releaseBusiness Wire
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
- Press releaseBusiness Wire
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
- NewsVandana Singh
Adagio Medical Heart Ablation System Shows 84% Freedom From Shock
- Press releaseBusiness Wire
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
- Press releaseBusiness Wire
Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseBusiness Wire
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System
- Press releaseBusiness Wire
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference
- Press releaseBusiness Wire
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
- Press releaseBusiness Wire
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
- Press releaseBusiness Wire
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
- Press releaseBusiness Wire
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)
- Press releaseBusiness Wire
Adagio Medical to Participate in the 38th Annual Roth Conference
- Press releaseBusiness Wire
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
- Press releaseBusiness Wire
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
- Press releaseBusiness Wire
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.